| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer
1 company
Curley Joanne is a Chief Development Officer at Vera Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 24 sells.
Estimated insider holdings value: $976K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2022 | VERA Vera Therapeutics, Inc. | Chief Development Officer | Sale+OE | 8,539 | $19.13 | $163,389.06 | -3.5% | -12.5% | -0.7% | |
| Aug 3, 2022 | VERA Vera Therapeutics, Inc. | Chief Development Officer | Sell | 988 | $16.81 | $16,608.28 | -5.4% | +4.6% | +3.8% | |
| Jul 19, 2022 | VERA Vera Therapeutics, Inc. | Chief Development Officer | Sale+OE | 11,444 | $16.01 | $183,271.09 | -13.5% | +21.7% | +2.5% | |
| Jul 14, 2022 | VERA Vera Therapeutics, Inc. | Chief Development Officer | Sale+OE | 9,104 | $15.14 | $137,863.71 | -18.8% | +28.9% | +9.4% | |
| Jul 7, 2022 | VERA Vera Therapeutics, Inc. | Chief Development Officer | Sale+OE | 9,666 | $15.05 | $145,453.39 | -12.4% | +40.4% | +7.2% | |
| Jun 22, 2022 | VERA Vera Therapeutics, Inc. | Chief Development Officer | Sale+OE | 1,545 | $15.01 | $23,197.95 | -3.1% | +47.0% | +10.8% | |
| Jun 17, 2022 | VERA Vera Therapeutics, Inc. | Chief Development Officer | Sale+OE | 5,887 | $15.04 | $88,565.49 | -7.3% | +53.5% | -7.5% | |
| May 31, 2022 | VERA Vera Therapeutics, Inc. | Chief Development Officer | Sale+OE | 400 | $15.22 | $6,086.20 | -1.6% | +50.1% | -42.6% |